# Poolbeg Pharma partner with Eurofins Genomics for AI data analysis (Interview)

- Link: https://www.directorstalkinterviews.com/poolbeg-pharma-partner-with-eurofins-genomics-for-ai-data-analysis-interview/4121027185
- Published: 2021-10-11T07:24:52+01:00
- Author: Giles

**[Poolbeg Pharma plc](https://www.directorstalkinterviews.com/company/poolbeg-pharma-plc/polb.l)**(
[LON:POLB](https://www.directorstalkinterviews.com/company/poolbeg-pharma-plc/polb.l))
CEO Jeremy Skillington joins DirectorsTalk Interviews to discuss partnering with
leading global biopharma services company Eurofins Genomics. Jeremy tells us more
about this exciting step in its AI data analysis programme, clarifies the ownership
of the human challenge samples, the next step in the data analysis programme, how
AI analysis will be used to discover new drugs and explains the benefits of analysing
data using AI.

Poolbeg Pharma plc is a clinical stage infectious disease pharmaceutical company,
with a novel capital light, clinical model which enables them to develop multiple
products faster and more cost effectively than the traditional biotech model.

Share on: